Gelatinous transformation of bone marrow following the use of dasatinib in a patient with philadelphia chromosome-positive acute lymphoblastic leukemia.
作者信息
Sharma Sanjeev Kumar, Choudhary Dharma, Handoo Anil, Kharya Gaurav, Gupta Nitin, Pavecha Punita, Chadha Ritu
机构信息
Department of Hemato-oncology and Bone Marrow Transplant, BL Kapur Superspeciality Hospital, Pusa Road, New Delhi, India.
出版信息
Leuk Res Rep. 2013 Jan 7;2(1):7-8. doi: 10.1016/j.lrr.2012.11.004. eCollection 2013.
Abstract
摘要
相似文献
1
Gelatinous transformation of bone marrow following the use of dasatinib in a patient with philadelphia chromosome-positive acute lymphoblastic leukemia.在一名费城染色体阳性急性淋巴细胞白血病患者中使用达沙替尼后出现的骨髓胶样变性。
Leuk Res Rep. 2013 Jan 7;2(1):7-8. doi: 10.1016/j.lrr.2012.11.004. eCollection 2013.
2
Gelatinous bone marrow transformation and emergence of clonal Philadelphia-negative cytogenetic abnormalities with excess blasts in a patient with chronic myeloid leukemia treated with dasatinib.
Anticancer Drugs. 2019 Apr;30(4):416-421. doi: 10.1097/CAD.0000000000000763.
3
Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.达沙替尼：一种用于治疗慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的酪氨酸激酶抑制剂。
Clin Ther. 2007 Nov;29(11):2289-308. doi: 10.1016/j.clinthera.2007.11.005.
4
Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion.达沙替尼诱导费城染色体阳性急性淋巴细胞白血病对既往含伊马替尼方案耐药患者异基因造血干细胞移植后完全分子缓解：1 例病例报告并讨论
Med Oncol. 2010 Dec;27(4):1123-6. doi: 10.1007/s12032-009-9347-0. Epub 2009 Nov 3.
5
Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia.基于微小残留病灶的一线达沙替尼联合化疗治疗成人费城染色体阳性急性淋巴细胞白血病的疗效和长期预后。
Ann Oncol. 2016 Jun;27(6):1081-1088. doi: 10.1093/annonc/mdw123. Epub 2016 Mar 6.
6
Prophylactic post-transplant dasatinib administration in a pediatric patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.对一名患有费城染色体阳性急性淋巴细胞白血病的儿科患者进行移植后预防性达沙替尼给药。
Pediatr Int. 2013 Jun;55(3):e56-8. doi: 10.1111/ped.12019.
7
Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment.达沙替尼治疗后血小板计数正常的费城染色体阳性急性淋巴细胞白血病患者发生自发性硬膜下血肿。
Platelets. 2015;26(5):491-4. doi: 10.3109/09537104.2014.935316. Epub 2014 Jul 15.
8
Dasatinib and Prednisolone Induction Therapy for a Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Dilated Cardiomyopathy Accompanied by Life-Threatening Ventricular Tachycardia.达沙替尼与泼尼松诱导治疗一例伴有扩张型心肌病并伴有危及生命的室性心动过速的费城染色体阳性急性淋巴细胞白血病患者。
Case Rep Hematol. 2017;2017:4027908. doi: 10.1155/2017/4027908. Epub 2017 Feb 23.
9
[Clinical Analysis of Dasatinib and Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia].达沙替尼联合化疗后行异基因造血干细胞移植治疗费城染色体阳性急性淋巴细胞白血病的临床分析
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Feb;28(1):18-23. doi: 10.19746/j.cnki.issn.1009-2137.2020.01.004.
10
Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.达沙替尼与伊马替尼治疗费城染色体阳性儿童急性淋巴细胞白血病的效果比较：一项随机临床试验。
JAMA Oncol. 2020 Mar 1;6(3):358-366. doi: 10.1001/jamaoncol.2019.5868.
引用本文的文献
1
Gelatinous transformation of bone marrow: rare or underdiagnosed?骨髓的胶样变性：罕见还是诊断不足？
Autops Case Rep. 2017 Dec 8;7(4):8-17. doi: 10.4322/acr.2017.039. eCollection 2017 Oct-Dec.
本文引用的文献
1
Recurrent bone marrow aplasia secondary to nilotinib in a patient with chronic myeloid leukemia: a case report.慢性髓性白血病患者中尼洛替尼继发的复发性骨髓再生障碍：一例报告
J Oncol Pharm Pract. 2012 Dec;18(4):440-4. doi: 10.1177/1078155212438112. Epub 2012 Mar 7.
2
Bone marrow with gelatinous transformation associated with residual disease in imatinib mesylate-treated chronic myelogenous leukaemia (CML).甲磺酸伊马替尼治疗的慢性粒细胞白血病（CML）中，骨髓呈胶样变性并伴有残留病。
Pathology. 2012 Jan;44(1):59. doi: 10.1097/PAT.0b013e32834e42df.
3
Successful management of gelatinous transformation of the bone marrow in anorexia nervosa with hematopoietic growth factors.应用造血生长因子成功治疗神经性厌食症骨髓胶样变性
Int J Eat Disord. 2011 Jul;44(5):469-72. doi: 10.1002/eat.20833. Epub 2010 Jun 30.
4
Gelatinous transformation of the bone marrow as a late morphological change in imatinib mesylate treated chronic myeloid leukaemia.骨髓的胶样变性作为甲磺酸伊马替尼治疗慢性髓性白血病的晚期形态学改变。
Pathology. 2010 Jan;42(1):84-5. doi: 10.3109/00313020903434686.
5
Gelatinous transformation of bone marrow in chronic myeloid leukemia during treatment with imatinib mesylate: a disease or a drug effect?
Acta Haematol. 2008;119(2):104-7. doi: 10.1159/000121825. Epub 2008 Mar 27.
6
Inhibition of platelet-derived growth factor receptorbeta by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro.甲磺酸伊马替尼抑制血小板衍生生长因子受体β可抑制人骨髓间充质干细胞的增殖并改变其体外分化。
Cell Prolif. 2007 Jun;40(3):355-66. doi: 10.1111/j.1365-2184.2007.00438.x.
7
Gelatinous transformation of bone marrow: a study of 43 cases.骨髓的胶样变性：43例研究
Indian J Pathol Microbiol. 2005 Jan;48(1):1-3.
8
Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.甲磺酸伊马替尼抑制转化生长因子-β的促纤维化活性，并预防博来霉素介导的肺纤维化。
J Clin Invest. 2004 Nov;114(9):1308-16. doi: 10.1172/JCI19603.
9
Reversal of bone marrow angiogenesis in chronic myeloid leukemia following imatinib mesylate (STI571) therapy.
Blood. 2004 May 1;103(9):3549-51. doi: 10.1182/blood-2003-08-2734. Epub 2004 Jan 15.
10
Gelatinous transformation of bone marrow following chemotherapy for myeloma.
Indian J Pathol Microbiol. 2001 Jan;44(1):53-4.
Zotero 插件